» Articles » PMID: 6238979

Clinical Correlates of Dementia and Disability in Huntington's Disease

Overview
Specialty Neurology
Date 1984 Nov 1
PMID 6238979
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship of duration of illness and severity of neurological impairment to psychometric performance and activities of daily living was examined in 57 patients with Huntington's Disease (HD). As earlier studies suggested, a distinct cognitive profile characterized patients early in the disease. Duration of symptoms, however, proved to be a weaker correlate of cognitive decline than was motor impairment at the time of testing. For predicting adaptive functioning, both duration of symptoms and neurological status were important variables. This study underscores the limitations of length of illness as a classificatory variable in studies of dementia in HD. We further suggest that future studies consider the contribution of defects in precise timing and sequential operations to the cognitive and adaptive deficits of these patients.

Citing Articles

Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease.

Baxa M, Levinska B, Skrivankova M, Pokorny M, Juhasova J, Klima J Dis Model Mech. 2019; 13(2).

PMID: 31704691 PMC: 6918771. DOI: 10.1242/dmm.041293.


Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.

Mestre T, Busse M, Davis A, Quinn L, Rodrigues F, Burgunder J Mov Disord Clin Pract. 2018; 5(4):361-372.

PMID: 30363510 PMC: 6174516. DOI: 10.1002/mdc3.12617.


Rutin as a Potent Antioxidant: Implications for Neurodegenerative Disorders.

Enogieru A, Haylett W, Hiss D, Bardien S, Ekpo O Oxid Med Cell Longev. 2018; 2018:6241017.

PMID: 30050657 PMC: 6040293. DOI: 10.1155/2018/6241017.


Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington's Disease Models.

Naia L, Rosenstock T, Oliveira A, Oliveira-Sousa S, Caldeira G, Carmo C Mol Neurobiol. 2016; 54(7):5385-5399.

PMID: 27590140 DOI: 10.1007/s12035-016-0048-3.


Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction.

Ross C, Pantelyat A, Kogan J, Brandt J Mov Disord. 2014; 29(11):1351-8.

PMID: 25216368 PMC: 4197404. DOI: 10.1002/mds.26012.